Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

References

• Mattalia A, Quaranta S, Leung PS, et al. Characterization of antimitochondrial antibodies in health adults. Hepatology. 1998;27:656–661.
   PubMed Web of Science ®Google Scholar
• Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291–308.
   PubMed Web of Science ®Google Scholar
• Heathcote J. Autoimmune cholangitis. Gut. 1997;40: 440–442.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Heathcote EJ. Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008;12:323–331.
   PubMed Web of Science ®Google Scholar
• Mendes F, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am. 2008;37:479–484.
   PubMed Web of Science ®Google Scholar
• Nakajima M, Shimizu H, Miyazaki A, et al. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? J Gastroenterol. 1999;34:607–612.
   PubMed Web of Science ®Google Scholar
• Invernizzi P, Crosignani A, Battezzati PM, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 1997;25:1090–1095.
   PubMed Web of Science ®Google Scholar
• Sakauchi F, Mori M, Zeniya M, et al. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2006;16:30–34.
   PubMed Web of Science ®Google Scholar
• Michieletti P, Wanless IR, Katz A, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut. 1994;35:260–265.
   PubMed Web of Science ®Google Scholar
• Lacerda MA, Ludwig J, Dickson ER, et al. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol. 1995;90:247–249.
   PubMed Web of Science ®Google Scholar
• Tsou Y-K, Yeh C-T. Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience. Chang Gung Med J. 2003;26:323–329.
   PubMedGoogle Scholar
• Zhang F-K, Jia J-D, Wang B-E. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int. 2004;3:288–291.
   PubMedGoogle Scholar
• Watanabe S, Deguchi A, Uchida N, et al. Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy. Hepatol Res. 2001;19:41–51.
   PubMed Web of Science ®Google Scholar
• Kim WR, Poterucha JJ, Jorgensen RA, et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology. 1997;26:22–26.
   PubMed Web of Science ®Google Scholar
• O’Donohue J, Wong T, Portmann B, et al. Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. Eur J Gastroenterol Hepatol. 2002;14:1143–1150.
   PubMed Web of Science ®Google Scholar
• Kaserer K, Exner M, Mosberger I, et al. Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch. 1998;432:217–222.
   PubMed Web of Science ®Google Scholar
• Muratori P, Muratori L, Gershwin ME, et al. “True” antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004;135:154–158.
   PubMed Web of Science ®Google Scholar
• Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology. 2001;34: 243–248.
   PubMed Web of Science ®Google Scholar
• Neuberger J, Bradwell AR. Anti-mitochondrial antibodies in primary biliary cirrhosis. J Hepatol. 2002;37:712–716.
   PubMed Web of Science ®Google Scholar
• Oertelt S, Rieger R, Selmi C, et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology. 2007;45:659–665.
   PubMed Web of Science ®Google Scholar
• Liu H, Norman GL, Shums Z, et al. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436–442.
   PubMed Web of Science ®Google Scholar
• Neuberger J, Thomson R. PBC and AMA – what is the connection? Hepatology. 1999;29:271–276.
   PubMed Web of Science ®Google Scholar
• Vleggaar FP, van Buuren HR. No prognostic significance of antimitochondrial antibody profile testing in primary biliary cirrhosis. Hepatogastroenterology. 2004;51:937–940.
   PubMed Web of Science ®Google Scholar
• Muratori L, Muratori P, Granito A, et al. The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis. Dig Liver Dis. 2005;37:108–112.
   PubMedGoogle Scholar
• Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45:118–127.
   PubMed Web of Science ®Google Scholar
• Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 1998;13:257–265.
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Omagari K, Whittingham S, et al. Autoimmune cholangitis and primary biliary cirrhosis – an autoimmune enigma. Liver. 1999;19:122–128.
   PubMedGoogle Scholar
• Hu C, Deng C, Song G, et al. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci. 2011;56:3357–3363.
   PubMed Web of Science ®Google Scholar
• Milkiewicz P, Buwaneswaran H, Coltescu C, et al. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol. 2009;7:1355–1360.
   PubMed Web of Science ®Google Scholar
• Ali AH, Sinakos E, Silveira MG, et al. Varices in early histological stage primary biliary cirrhosis. J Clin Gastroenterol. 2011;45:e66–e71.
   PubMed Web of Science ®Google Scholar
• Floreani A, Caroli D, Variola A, et al. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int. 2011;31:361–368.
   PubMed Web of Science ®Google Scholar
• ter Borg PCJ, Schalm SW, Hansen BE, et al. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol. 2006;101:2044–2050.
   PubMed Web of Science ®Google Scholar
• Yokokawa J, Saito H, Kanno Y, et al. Overlap of primary biliary cirrhosis and autoimmune hepatitis: characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol. 2010;25:376–382.
   PubMed Web of Science ®Google Scholar
• Neuhauser M, Bjornsson E, Treeprasertsuk S, et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol. 2010;105:345–353.
   PubMed Web of Science ®Google Scholar